Lower dose of insulin-sensitizing drug benefits patients with Type 2 diabetes - Medical Xpress
An insulin-sensitizing drug can benefit patients with insulin resistance at lower doses than has typically been prescribed, according to a study co-authored by Paresh Dandona, MD, Ph.D., SUNY Distinguished Professor of Medicine in the Jacobs School of Medicin…
Efficacy and adverse events by treatment and mode dose taken. Forest plot shows the rate and adjusted hazard ratios (HRs) of outcomes by strata of mode dose of pioglitazone compared with placebo, for… [+5423 chars]
Read More
Other Stories in Health
- Women remain underserved in cardiovascular disease treatment despite advances
- Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab
- Through the eyes of a cat – biomimicry of feline eyes may revolutionize robotic vision
- 5 Lessons About Change I Learned from Moving to a New City
- Mpox clade 1b, the strain declared public health emergency by WHO, found in Kerala
- New York resident dies from EEE; state declares virus 'imminent public health threat'
- Pace University ABSN Spring 2025
- Health minister warns retailers still selling illegal vapes could soon face prosecution, months after ban took force
- Stage I vs. Stage IV: A Guide To Understanding Your Breast Cancer From Diagnosis To Treatment
.png)
